Include: 1 videos 1 pdf, size: 4.54 GB
This program was created and named in honor of Dr. Jorge H. Mestman, a dedicated physician, teacher and mentor to many for more than 40 years and going. His significant contributions to the field of endocrine in pregnancy continue to shape how we practice today. His philosophy of excellence in patient care and his values of integrity and collaboration are the foundations of this symposium. The goal of this program is to provide a comprehensive and current update in the management of endocrine disease as related to pregnancy, a unique and challenging time in patients’ lives. Management of endocrine disease during pregnancy has become increasingly multifaceted as new evidence-based management strategies emerge. This inaugural program presents standards of practice as well as forward-looking perspectives representing the most current state of endocrine medicine. The talks focus on recent advancement and recommendations in the management of gestational diabetes, the long-term impact of metabolic disease for mother and child, the role of advanced technologies including continuous glucose monitors, and fetal ultrasound, unique considerations in pregnancy for patients with PCOS, pituitary disease, and Graves’ Hyperthyroidism, and the current debate of universal thyroid screening. Presentations combining evidence-based medicine and clinical experience, challenging cases, and panel discussions from audience questions, help inform practice decisions in an era of complex clinical challenges.
- Counsel patients diagnosed with gestational diabetes in regards to screening, medical management, lifestyle changes, pregnancy and postpartum implications to mother and child, and available technologies.
- Conduct preconception counseling with patients with Graves’ Hyperthyroidism and develop an approach to medication choice and titration during pregnancy.
- Examine the unique challenges for caring for patients with PCOS and pituitary disease to best optimize care prior to, during and after pregnancy.
- Assess the role of new technologies such as continuous glucose monitors and ultrasound in the management of patients with endocrine conditions in pregnancy.
Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
February 19.mp4 ( 5 hours)
Syllabus.pdf
*Detail:
7:30 am Conference Login Begins
7:45 am Welcome and Announcements Caroline T. Nguyen, MD and Richard H. Lee, MD
Session I: Moderators: Caroline T. Nguyen, MD and Richard H. Lee, MD
7:50 am Conference Opening Peter A. Singer, MD
8:05 am Clinical Update: Screening and Counseling for Patients with Gestational Diabetes Steven Gabbe, MD
8:30 am Metformin, for Gestational Diabetes: Quick Fix or Unforseen Offspring Consequences Linda Barbour, MD, MSPH
8:55 am Shaping Future Health: Early-Life Determinants of Brain and Metabolic Disease Risk Kathleen A. Page, MD
9:20 am Questions & Answers Faculty Panel
9:35 am Break
Session II: Moderators: Caroline T. Nguyen, MD and Richard H. Lee, MD
9:50 am The Role of Continuous Glucose Monitors in the Management of Diabetes in Pregnancy—A Game Changer? Sarit Polsky, MD, MPH
10:15 am Unique Challenges of Fertility and Pregnancy for Patients with PCOS Sarah L. Berga, MD
10:40 am Avoiding Pitfalls in the Management of Pituitary Disease During Pregnancy John Carmichael, MD
11:05 am Questions & Answers Faculty Panel
11:20 am Break
Session III: Moderators: Caroline T. Nguyen, MD and Richard H. Lee, MD
11:40 am Clinical Considerations in Caring for the Pregnant Patient with Graves’ Disease Caroline T. Nguyen, MD
12:05 pm A Picture is Worth a Thousand Words – The Role of Fetal Ultrasound in Endocrine DiseaseRichard H. Lee, MD
12:30 pm Universal Thyroid Screening—Where Do We Stand? Alex Stagnaro-Green MD, MHPE
12:55 pm Questions & Answers Faculty Panel
1:10 pm Closing Remarks Caroline T. Nguyen, MD and Richard H. Lee, MD
1:15 pm Adjourn
Related products
Uncategorized